India’s medical technology sector has reached an important milestone with the installation of the first Made-in-India FUJIFILM EP-6000 Endoscopy System at the All India Institute of Medical Sciences (AIIMS), New Delhi. The system, bearing serial number 001, has been dedicated to the nation through AIIMS and is being used by the institute’s Department of Gastroenterology. The development comes only months after FUJIFILM India began endoscopy manufacturing operations in Jodhpur, Rajasthan, making the AIIMS installation an early demonstration of the country’s expanding capabilities in locally manufactured advanced medical equipment.

The significance of the development extends beyond the installation of a single medical device. Endoscopy is an important part of modern gastrointestinal medicine because it allows doctors to directly examine parts of the digestive system and, depending on the procedure, identify abnormalities, collect tissue samples and perform certain therapeutic interventions. The quality of the imaging system can therefore play an important role in helping clinicians examine the gastrointestinal tract. At AIIMS, where large numbers of patients are treated and complex cases are routinely managed, the addition of an advanced locally manufactured system represents both a clinical and industrial milestone.

FUJIFILM India said the EP-6000 installed at AIIMS is the first serial-numbered Made-in-India Fujifilm endoscopy system and was manufactured through the company's contract manufacturing facility in Jodhpur. The company formally dedicated the system to the nation on September 21, 2026, in an event involving Union Health Minister Jagat Prakash Nadda, FUJIFILM India Managing Director Koji Wada and senior AIIMS officials. The company described the development as part of its wider contribution to India's medical technology manufacturing journey and its commitment to the government's Make in India initiative.

The AIIMS installation follows the inauguration of Fujifilm's endoscopy manufacturing operations in Jodhpur in February 2026. According to Fujifilm, the Jodhpur operation uses a local manufacturing partner and is intended to progressively localise the production of endoscopy systems while maintaining the company's stated Japanese quality standards and production processes. The company has said the initiative is designed to strengthen India's domestic endoscopy manufacturing base and improve access to advanced minimally invasive diagnostic technologies.

Why the EP-6000 installation matters

For years, advanced medical equipment in India has included a significant imported component. Establishing domestic manufacturing for sophisticated diagnostic systems therefore has implications beyond the particular hospital receiving the first unit. Local production can potentially shorten supply chains, develop technical capabilities, create manufacturing expertise and make it easier for companies to build service and support ecosystems closer to healthcare institutions. However, the precise impact on prices, import dependence and overall access will depend on how substantially manufacturing becomes localised and how production scales over time.

Fujifilm's Jodhpur initiative is significant in this context because the company is not presenting the facility simply as an assembly operation with no wider ambition. Its February announcement said the manufacturing programme would progressively localise endoscopy systems and could eventually support neighbouring markets. The company also said India could become an emerging regional manufacturing and supply base within its global healthcare network.

That potential is particularly relevant as India's healthcare system expands. The country's population, growing demand for specialised medical services and increasing emphasis on early detection are creating demand for sophisticated diagnostic technologies. At the same time, healthcare institutions face pressure to deliver those technologies at scale and at sustainable cost. Domestic manufacturing cannot solve all of these challenges by itself, but it can become one part of a broader strategy involving manufacturing, clinical training, research, maintenance infrastructure and healthcare investment.

The AIIMS installation gives that strategy a highly visible institutional setting. AIIMS New Delhi is one of India's major tertiary-care medical institutions and manages patients requiring highly specialised treatment. The first serial-numbered system being placed there means that a locally manufactured Fujifilm platform has entered one of the country's most prominent clinical environments.

Prof. Nikhil Tandon, Director of AIIMS New Delhi, said the institute has a longstanding commitment to adopting advanced medical technologies and clinical innovation. He described the installation as a meaningful addition to AIIMS's capabilities and highlighted the importance of advanced diagnostic and therapeutic technologies in institutions that serve patients at scale.

Prof. Pramod Garg, Professor and Head of the Department of Gastroenterology and Human Nutrition Unit at AIIMS, similarly welcomed the establishment of endoscope manufacturing in India and said the new system would add to the department's ability to serve patients.

What an advanced endoscopy system does

Endoscopy allows physicians to examine internal structures of the gastrointestinal tract using a flexible instrument equipped with a camera and illumination system. Modern endoscopy has developed far beyond the simple concept of inserting a camera and viewing an image. Contemporary systems combine high-resolution imaging, specialised illumination, image processing and increasingly computer-assisted technologies to help clinicians distinguish subtle changes in tissue.

Fujifilm's broader 6000-series endoscopy ecosystem incorporates technologies designed to enhance visualisation. The company's India materials describe multi-LED illumination and image-processing technologies, including Blue Light Imaging, or BLI, and Linked Color Imaging, or LCI. BLI is designed to enhance the visualisation of fine blood vessels and mucosal microstructures, while LCI is intended to emphasise subtle colour differences in endoscopic images, particularly differences involving red tones.

These technologies matter because gastrointestinal abnormalities can sometimes involve relatively subtle changes in surface structure or colour. Enhanced imaging does not replace the judgement of a trained physician, but it can provide clinicians with additional visual information during an examination. The purpose is to make important features easier to observe and potentially support more informed clinical decisions.

Fujifilm's published information on its 6000-series scopes also describes compatibility with different observation modes, including white light, BLI and LCI on selected systems. The company lists scopes with different viewing fields, working lengths, bending capabilities and instrument-channel sizes depending on the particular application.

The EP-6000 platform can also work with Fujifilm's CAD EYE computer-aided diagnosis technology. Fujifilm describes CAD EYE as an endoscopy support programme developed using artificial intelligence and deep-learning technology based on clinical images. Its published specifications list EP-6000 among the compatible systems for selected upper gastrointestinal and colon applications.

It is important, however, not to confuse the availability of such technologies within the broader EP-6000 ecosystem with a claim that every AIIMS procedure performed using the newly installed system automatically uses every advanced imaging or AI feature. The exact configuration, compatible scopes and software in clinical use depend on the equipment installed and the procedures being performed.

The Jodhpur connection

Perhaps the most important part of this story is not inside the AIIMS gastroenterology department but several hundred kilometres away in Rajasthan.

In February 2026, Fujifilm announced the inauguration of endoscopy manufacturing in Jodhpur. The company said the facility would manufacture Made-in-India products through a local manufacturing partner and that production would follow its stated Japanese quality and localisation standards. Fujifilm said the initiative was intended to build India's domestic endoscopy base while addressing the growing demand for high-performance diagnostic technologies.

The company also highlighted the role of advanced illumination and image processing in the locally manufactured systems. Its description of the manufacturing initiative referred to LED light sources capable of controlling multi-colour illumination and technologies such as BLI and LCI for enhanced image interpretation during endoscopic examinations.

The establishment of this manufacturing capability reflects a broader shift in India's medical-device landscape. Medical equipment is becoming an increasingly important component of the country's industrial and healthcare policy discussions. While India has developed substantial pharmaceutical manufacturing capabilities, sophisticated medical devices present a different technological challenge. They require precision manufacturing, specialised components, electronics, optics, software, quality control and long-term servicing.

Endoscopy systems bring many of these requirements together. The devices involve optical components, cameras, illumination, flexible mechanical structures, image processing and specialised software. Manufacturing them domestically therefore requires more than simply establishing a conventional production line. It requires a supporting ecosystem of suppliers, trained engineers, quality systems, regulatory processes and service capabilities.

The Jodhpur facility is consequently significant as part of an industrial ecosystem rather than simply as a building where equipment is assembled. Whether India's localisation ambitions ultimately produce a large-scale domestic medical-device industry will depend on the development of that wider ecosystem.

From imported technology to local manufacturing

The phrase "Made in India" can mean different things depending on the degree of localisation involved. A medical device may contain components manufactured in several countries while undergoing final production or assembly in India. For this reason, the development of domestic manufacturing should be viewed as a process rather than an overnight transition from imported products to completely indigenous systems.

Fujifilm itself describes the Jodhpur initiative as progressive localisation. Its announcement says the company intends to progressively localise endoscopy systems to meet demand for advanced diagnostic solutions.

That distinction is important when assessing what the AIIMS installation represents. The achievement is not necessarily that every component of the EP-6000 originates from India. Rather, the development demonstrates that an advanced Fujifilm endoscopy system is being manufactured in India within the company's localisation programme and that the first serial-numbered unit has been placed at a major Indian medical institution.

This approach could have practical implications for future production. As manufacturing volumes increase, companies can potentially deepen local sourcing, train additional personnel and establish more specialised supplier networks. But those outcomes are not automatic. They require sustained investment, demand, technical capability and quality assurance.

The first unit at AIIMS therefore represents the beginning of a manufacturing journey rather than its conclusion.

Potential implications for patients

For patients, the most important question is ultimately whether technological and manufacturing developments translate into better healthcare.

An advanced endoscopy platform can support doctors by providing detailed visual information during gastrointestinal examinations. Better visualisation may be particularly relevant when physicians are looking for subtle mucosal abnormalities or vascular patterns. Specialised imaging modes can provide information that complements conventional white-light examination.

At AIIMS, the scale of patient care gives the installation particular importance. The institution handles a large volume of specialised cases, and its gastroenterology department performs diagnostic and therapeutic procedures across a broad range of gastrointestinal conditions.

The system was donated by Fujifilm India as a goodwill gesture, according to reports on the installation.

The immediate effect is therefore the addition of another advanced endoscopy capability within the department. The longer-term question is how such technology becomes available across India's wider healthcare system, including government hospitals, teaching institutions and facilities outside the largest metropolitan centres.

A locally manufactured system could potentially contribute to that expansion if domestic production grows and supply chains become more efficient. But affordability and access will depend on multiple factors, including procurement policies, hospital budgets, maintenance costs, clinical staffing and the availability of trained specialists.

Beyond the machine: training and clinical expertise

Medical technology is only as useful as the people and systems surrounding it.

An advanced endoscopy platform requires trained gastroenterologists, technicians, nurses and support personnel. Physicians need to understand not only how to operate the equipment but also how to interpret the images generated by different imaging modes. Hospitals need maintenance and servicing arrangements to ensure equipment remains reliable.

AIIMS's involvement is therefore relevant not only because it is receiving the first unit but also because the institution is a major centre for clinical education and specialised medicine. The presence of advanced technology in such an environment can provide opportunities for clinicians and trainees to work with newer imaging platforms.

The development also highlights the relationship between technology companies and public healthcare institutions. Companies can manufacture advanced systems, but hospitals provide the clinical environment in which those systems are evaluated and used. Over time, interactions between manufacturers, clinicians and researchers can influence how technologies are adapted to real-world healthcare requirements.

The wider Make in India story

The EP-6000 installation is also part of a much larger effort to increase domestic production of medical equipment.

India's healthcare technology requirements are enormous. The country has a large population, major public and private hospital networks and increasing demand for sophisticated diagnostic and therapeutic procedures. A greater domestic manufacturing base could potentially improve resilience in the medical supply chain.

The COVID-19 pandemic demonstrated how disruptions to global supply chains can affect healthcare systems. Medical devices, components and other healthcare products can be affected by international transportation problems, shortages and geopolitical disruptions. Domestic manufacturing does not eliminate exposure to global supply chains, particularly when specialised components continue to be imported, but it can diversify sources of production.

Fujifilm has linked its Jodhpur initiative directly to India's Make in India policy. The company has also said it is considering expanding the scope of Made-in-India offerings to neighbouring markets, potentially positioning India as a regional manufacturing and supply base within its global healthcare network.

If such plans expand, India could potentially move from being primarily a large market for medical technologies to also becoming a production and export base for selected categories of advanced medical equipment. That would have implications for manufacturing jobs, engineering expertise, supply chains and exports.

But the scale of that transformation will depend on future investment and localisation. A single installation is a milestone, but it does not by itself establish a large domestic industry.

Why AIIMS is an important location for the first system

The choice of AIIMS New Delhi for the first serial-numbered system carries symbolic and practical significance.

AIIMS is one of India's most recognised public medical institutions and has a major role in specialised patient care, medical education and clinical research. Installing the first Made-in-India EP-6000 there places the new technology within an institution that treats patients from across the country.

For Fujifilm, the installation also provides a visible demonstration of its Indian manufacturing programme. For the government, it aligns with the broader objective of increasing domestic medical-device capability. For AIIMS, it adds another advanced diagnostic technology to a department dealing with a substantial clinical workload.

That convergence is what makes the announcement more than a routine equipment installation.

What comes next

The next stage will be watching whether the Jodhpur manufacturing initiative develops beyond the first EP-6000 system.

The real measure of localisation will involve questions such as how much production is ultimately carried out in India, whether local suppliers become part of the manufacturing chain, whether additional endoscopy systems are produced domestically, whether India becomes an export base and whether the resulting products become more accessible to healthcare providers.

There is also a broader question about how India develops domestic expertise in medical-device engineering. Pharmaceutical manufacturing has created a large technical ecosystem, but sophisticated medical devices require expertise across electronics, optics, mechanical engineering, software, imaging and clinical applications.

If manufacturing programmes succeed in creating these capabilities, their impact could extend beyond one company or one category of equipment.

For healthcare providers, reliability will remain central. Medical equipment cannot be evaluated solely by where it is manufactured. Hospitals need systems that meet regulatory requirements, perform consistently, can be serviced efficiently and are supported by appropriate training. Domestic manufacturing can strengthen these areas, but quality assurance must remain a continuing process.

The AIIMS installation therefore offers an opportunity to examine India's medical-device ambitions through a practical example. The country is attempting to build greater domestic capability while continuing to integrate advanced technologies developed through international partnerships and global companies.

A milestone, but also a beginning

The installation of the first Made-in-India EP-6000 Endoscopy System at AIIMS Delhi is a notable development in India's medical technology landscape. The system was manufactured through Fujifilm India's Jodhpur manufacturing programme, carries serial number 001 and has been dedicated to the nation through one of India's leading public medical institutions.

Its significance lies in the combination of three developments: advanced clinical technology, domestic manufacturing and the growing demand for specialised healthcare in India.

For patients, the immediate story is about access to an advanced endoscopy system at a major hospital. For doctors, it is about additional imaging capabilities that can support gastrointestinal examination. For the medical-device industry, it represents an early example of high-technology endoscopy manufacturing taking place in India. For policymakers, it illustrates the possibilities and challenges involved in building domestic capability in a technically demanding sector.

The Jodhpur manufacturing facility is particularly important because it suggests that the AIIMS installation is intended to be part of a broader manufacturing programme rather than an isolated event. Fujifilm has stated that it plans to progressively localise its endoscopy offerings and has indicated that India could become a regional supply base.

The longer-term impact will depend on what follows. If production expands, local supply chains deepen and advanced medical technologies become increasingly available to hospitals across India, the first EP-6000 at AIIMS could eventually be viewed as an early marker in a much larger transformation.

For now, the serial number 001 carries a straightforward message. An advanced endoscopy system that was previously part of an international medical-technology supply chain has now begun a new chapter in India, with its first locally manufactured unit installed at AIIMS New Delhi.

That is the story beyond the headline. It is not simply about a new machine arriving at a hospital. It is about whether India can turn growing healthcare demand into domestic technological capability, whether international companies can build meaningful manufacturing ecosystems in the country, and whether those investments ultimately translate into better and more accessible healthcare.

The first EP-6000 at AIIMS is therefore best understood as a starting point. The significance of the milestone will ultimately be measured not by the first machine alone, but by what India builds around it.

#BeyondHeadlines #AIIMSDelhi #Endoscopy #EP6000 #MadeInIndia #MedicalTechnology #HealthcareIndia #FujifilmIndia #MakeInIndia #MedicalDevices #Gastroenterology #HealthcareInnovation #AtmanirbharBharat